Therapeutic Advances in Psychopharmacology

Top Research Topics at Therapeutic Advances in Psychopharmacology?

The aim of Therapeutic Advances in Psychopharmacology is to expand the discussion of research in Psychiatry, Schizophrenia, Antipsychotic, Internal medicine and Clozapine. The studies in Psychiatry featured incorporate elements of Long acting, Pediatrics and Clinical psychology. It focused on Clinical psychology research but expanded to cover Anxiety.

In addition to Schizophrenia research, it aims to explore topics under Psychosis and Adverse effect. The study on Adverse effect presented is investigated in conjunction with research in Intensive care medicine. The Antipsychotic works featured in Therapeutic Advances in Psychopharmacology incorporate elements from Risperidone and Polypharmacy.

The journal explores issues in Internal medicine which can be linked to other research areas like Endocrinology, Pharmacology, Oncology and Atypical antipsychotic. The research on Clozapine featured in Therapeutic Advances in Psychopharmacology combines topics in other fields like Anesthesia and Neutropenia. The journal features Depression (differential diagnoses) research that overlaps with concepts in Ketamine.

• Psychiatry (53.88%)
• Schizophrenia (28.57%)
• Antipsychotic (20.30%)

What are the most cited papers published in the journal?

• Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review (242 citations)
• Cannabis, a complex plant: different compounds and different effects on individuals. (180 citations)
• The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal (138 citations)

Research areas of the most cited articles at Therapeutic Advances in Psychopharmacology:

The journal publications mainly tackle studies in Psychiatry, Schizophrenia, Psychosis, Antipsychotic and Neuroscience. The most cited papers hold forums on Psychiatry that merge themes from other disciplines such as Lysergic acid diethylamide and Clinical psychology. While work presented in the most cited articles provide substantial information on Schizophrenia, it also covers topics in Systematic review, Obesity and Incidence (epidemiology).

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Psychiatry

The previous edition focused in particular on these issues:

The scientific interests tackled in the journal are Schizophrenia, Psychiatry, Antipsychotic, Internal medicine and Clozapine. Therapeutic Advances in Psychopharmacology focuses on Schizophrenia but the discussions also offer insight into other areas such as Intensive care medicine, Psychopharmacology, Plasma levels, Long acting and Psychiatric hospital. Psychiatry research featured in the journal incorporates concerns from various other topics such as Polypharmacy and Panacea (medicine).

While work presented in Therapeutic Advances in Psychopharmacology provided substantial information on Antipsychotic, it also covered topics in Psychological intervention, Aripiprazole, Bipolar disorder, Bipolar I disorder and Schizophrenia (object-oriented programming). The close relationship between Depression (differential diagnoses) and Ketamine is one of the points of interest dissected in Internal medicine research. The work on Clozapine tackled in the journal brings together disciplines like Weight gain, Psychosis and Pediatrics.

The most cited articles from the last journal are:

• Liquorice for pain (6 citations)
• The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?: (5 citations)
• What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Therapeutic Advances in Psychopharmacology (based on the number of publications) are:

• David Taylor (35 papers) published 3 papers at the last edition, 4 less than at the previous edition,
• Derek K. Tracy (10 papers) published 1 paper at the last edition the same number as at the previous edition,
• Peter M. Haddad (9 papers) absent at the last edition,
• Eromona Whiskey (7 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Thomas R. E. Barnes (7 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutic Advances in Psychopharmacology (based on the number of publications) are:

• King's College London (46 papers) published 6 papers at the last edition, 1 more than at the previous edition,
• South London and Maudsley NHS Foundation Trust (27 papers) published 4 papers at the last edition, 4 less than at the previous edition,
• Imperial College London (10 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• University of Cambridge (10 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• University College London (9 papers) published 1 paper at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.33% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.64% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.69% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.38% of all publications and 51.28% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Online Research and Learning Opportunities in Psychopharmacology

With the rise in virtual learning platforms, several nursing schools are offering comprehensive online courses in Psychopharmacology. Taking these online courses helps to gain more insight into the research topics discussed in this article such as Psychiatry, Schizophrenia, Antipsychotic, Internal Medicine, and Clozapine amongst others. These online courses typically cover a broad range of topics, including the principles of psychopharmacology, the biology of psychoactive drugs, the latest therapeutic applications, and ethical issues related to their use. Engaging in these virtual learning experiences enables learners to stay updated with advancements and the implications of psychopharmacology in therapeutic care. Whether you are a working professional looking to enhance your knowledge or a student aiming to broaden your understanding in this field, enrolling in these online courses could provide you with a flexible opportunity to dive into a comprehensive psychopharmacological study. One of such programs worth considering is featured in the {anchor}. This program offers a thorough curriculum and an immersive online learning environment in nursing with a concentration in psychopharmacology. Hence, it is considered to be one of the best online nursing schools in best online nursing programs in connecticut.